Consistently, in cancer cells exposed to immuno-oncologic death ligands such as TRAIL, the PARP1-meidated HMGB1 cytosolic translocation axis maintains autophagic flux to prevent apoptosis, thereby contributing to TRAIL resistance. This evidence concerns the gene HMGB1 and cancer.